October 31, 2008 - Surface modification and drug delivery technologies company SurModics Inc. said today it is providing advanced hydrophilic coating technology for Elixir Medical Corp’s drug-eluting and bare metal stent systems, which are designed to optimize vessel scaffolding and localized drug delivery to provide a safe and effective treatment for cardiovascular patients.

Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disease.

Mennen Medical recently released a new cath lab hemodynamic monitoring system, the Horizon XVu, which is embedded with a reportedly ultra modern interface and analysis system, includes network ability and efficient workflow connectivity as part of Mennen’s total IT solution. The new software displays eight main focus areas.

The ClariTEE miniaturized transesophageal echocardiography probe facilitates episodic monitoring of cardiac function. It is a single-use device that can remain indwelling for up to 72 hours, allowing intensivists and anesthesiologists to periodically assess cardiac preload and left ventricular systolic function over a prolonged period of time.

CardioECG 3.2, introduced by LUMEDX Corp. and Epiphany Cardiography Products, is a multimodality, multivendor, pure-Web software for cardiac rhythm data management.

By delivering clinical data from more than 60 different devices and over 30 vendors across 10 different modalities such as cardiograph, Holter, stress, patient monitoring, PF, and defibrillator, CardioECG is said to streamline data management, support best-of-breed clinical environments and significantly reduce total cost of ownership.

Hospitals today need software fast enough to accommodate high-volume clinical areas like cardiology, surgery and peripheral vascular, while providing flexibility for the unique needs of all departments, and LUMEDX said its new scheduling system meets these demands.

Boston Scientific's TAXUS Express2 Atom paclitaxel-eluting coronary stent system is a drug-eluting stent (DES) specifically designed for treating small coronary vessels. The TAXUS Express2 Atom Stent System is the only DES approved by the FDA for use in vessels as small as 2.25 mm in diameter, Boston Scientific said.

The Taxus Express 2 Atom received FDA approval in the fall of 2008.

Navilyst Medical offers an enhanced PICC Convenience Kitting and a new Xcela Power Injectable Port catheter provide a means for long-term delivery of fluids and medications including chemotherapy, and a new EZ Huber Safety Infusion Set offers a dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure.

Micrus Endovascular Corp. launched the Cerecyte and stretch-resistant versions of its DeltaPaq microcoil system for the treatment of cerebral aneurysms.

The FDA granted approval for Covidien’s generic kit for the preparation of technetium Tc99m Sestamibi injection use for nuclear myocardial perfusion imaging.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now